Topics

Medicine and Health

3:54 a.m. July 16, 2021 - By Joseph Walker
Cleveland Clinic, Mount Sinai and Providence won’t give Biogen’s new Alzheimer’s drug The three hospital operators are holding off on administering Aduhelm amid a debate over its effectivenessThree large hospitals are declining to administer Biogen Inc.’s new Alzheimer’s treatment, Aduhelm, the latest rupture to emerge from the Food and Drug Administration’s controversial approval of the drug last month.
Browse topics:
Link to MarketWatch's Slice.